Angiotech Pharmaceuticals Announces Conference Call And Webcast - Fourth Quarter And Year End 2012 Financial Results
VANCOUVER, March 18, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2012, on Tuesday, April 2, 2013 at 10:00 am PT ( 1:00 pm ET).
Dial-in information for the earnings call on April 2, 2013 is as follows: North America (toll-free): (877) 299-4454 International: (617) 597-5447 Enter Passcode: 11331267
A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investors section.
A press release announcing Angiotech's financial results will be issued prior to the call on April 1 st at approximately 1:00 pm PT ( 4:00 pm ET).An archived replay of the call will be available until April 9, 2013. Replay information is as follows: North America (toll-free): (888) 286-8010 International: (617) 801-6888 Enter Passcode: 68121746 About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech, please visit our website at www.angiotech.com. SOURCE Angiotech Pharmaceuticals, Inc.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV